ClinicalTrials.gov record
Completed Phase 3 Interventional

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

ClinicalTrials.gov ID: NCT00023972

Public ClinicalTrials.gov record NCT00023972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 30, 2026, 3:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Multicenter Phase III Study Comparing the Efficacy and Safety of a Combination of Intravenous DX-8951f (Exatecan Mesylate) Plus Gemcitabine to Gemcitabine Alone in Patients With Locally Advanced or Metastatic Cancer of the Exocrine Pancreas Who Have Not Received Prior Chemotherapy

Study identification

NCT ID
NCT00023972
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • exatecan mesylate Drug
  • gemcitabine hydrochloride Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2001
Primary completion
Mar 31, 2005
Completion
Mar 31, 2005
Last update posted
May 15, 2012

2001 – 2005

United States locations

U.S. sites
66
U.S. states
27
U.S. cities
62
Facility City State ZIP Site status
Intouch Research Huntsville Alabama 35801
Providence Cancer Center Mobile Alabama 36608
Arizona Clinical Research Center Tucson Arizona 85712
Medical Oncology/Hematology Gilroy California 95020
California Cancer Care, Inc. Greenbrae California 94904-2007
Pacific Shores Medical Group Long Beach California 90813
Cancer and Blood Institute of the Desert Rancho Mirage California 92270
Sutter Cancer Center Sacramento California 95816
University of Colorado Cancer Center Denver Colorado 80010
Medical Oncology and Hematology, P.C. Hamden Connecticut 06518
nTouch Research Melbourne Florida 32901
Sylvester Cancer Center, University of Miami Miami Florida 33136
MD Anderson Cancer Center Orlando Orlando Florida 32806
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612
Peachtree Hematology and Oncology Consultants, P.C. Atlanta Georgia 30309
Emory University School of Medicine Atlanta Georgia 30322
Central Georgia Hematology Oncology, P.C. Macon Georgia 31201
Cancer Research Center of Hawaii Honolulu Hawaii 96813-2424
Northwestern Memorial Hospital Chicago Illinois 60611-5933
Lutheran General Cancer Care Center Park Ridge Illinois 60068
Hope Center Terre Haute Indiana 47802
Harbor Hospital Center Baltimore Maryland 21215-1290
Oncology-Hematology Associates, P.A. Clinton Maryland 20735
Providence Hospital Cancer Center Southfield Michigan 48075
Virginia Piper Cancer Institute Minneapolis Minnesota 55407
St. Joseph Oncology, Inc. Saint Joseph Missouri 64507
St. Louis University Health Sciences Center St Louis Missouri 63110-0250
Midwest Hematology Oncology Consultants, Ltd. St Louis Missouri 63136
Billings Oncology Associates Billings Montana 59101
Great Falls Clinic Great Falls Montana 59405
Nevada Cancer Center Las Vegas Nevada 89109
Center for Cancer And Hematologic Disease Cherry Hill New Jersey 08046
Hematology Oncology Associates Morristown New Jersey 07962
Hematology and Oncology Group Somerset New Jersey 08873
Summit Medical Group, P.A. Summit New Jersey 07901
HemOnCare, P.C. Brooklyn New York 11235
Mary Imogene Bassett Hospital Cooperstown New York 13326
Nassau Hematology/Oncology PC Lake Success New York 11042
Memorial Sloan-Kettering Cancer Center New York New York 10021
State University of New York Health Sciences Center - Stony Brook Stony Brook New York 11794-8174
New York Medical College Valhalla New York 10595
Buffalo Medical Group, P.C. Williamsville New York 14221
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295
Duke Comprehensive Cancer Center Durham North Carolina 27710
N.W. Carolina Oncology & Hematology, P.A. Hickory North Carolina 28602
Ireland Cancer Center Cleveland Ohio 44106-1714
Cleveland Clinic Cancer Center Cleveland Ohio 44111
Mid-Ohio Oncology/Hematology, Inc. Columbus Ohio 43222
Medical Oncology Associates of Wyoming Valley, P.C. Kingston Pennsylvania 18704-5527
Lancaster Cancer Center Lancaster Pennsylvania 17604
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104
Lifespan: The Miriam Hospital Providence Rhode Island 02906
Memorial Hospital Cancer Center - Chattanooga Chattanooga Tennessee 37404
Williamson Medical Center Franklin Tennessee 37067
Family Cancer Center Germantown Tennessee 38138
Jackson-Madison County General Hospital Jackson Tennessee 38301
Sarah Cannon-Minnie Pearl Cancer Center Nashville Tennessee 37203
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6307
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410-1894
Cancer Therapy and Research Center San Antonio Texas 78229-3271
Scott and White Memorial Hospital Temple Texas 76502
Central Utah Medical Clinic Provo Utah 84604
Intermountain Hematology/Oncology Associates, Inc. Salt Lake City Utah 84124-1363
Rainier Oncology Puyallup Washington 98372
Yakima Regional Cancer Care Center Yakima Washington 98902
UW Cancer Center Wausau Hospital Wausau Wisconsin 54401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00023972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2012 · Synced Apr 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00023972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →